Radical Relay Methods for Selective C-H Oxidation

选择性 C-H 氧化的自由基接力方法

基本信息

  • 批准号:
    9767243
  • 负责人:
  • 金额:
    $ 29.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary Oxidation reactions exhibit significant value in the synthesis of pharmaceuticals, natural products and other bioactive compounds. The proposed studies will develop powerful new synthetic methods for selective oxidative functionalization of C(sp3)–H bonds. Benzylic C–H bonds represent a strategic target: such bonds are ubiquitous in pharmaceuticals and they are comparatively weak relative to most other C–H bonds. The latter feature provides the basis for selective functionalization of these sites via radical intermediates. In addition, benzylic sites often contribute to the metabolic instability of pharmaceuticals, and their selective modification will confer enhanced biological potency. Our efforts target the development of synthetic methods that may be readily adapted to pharmaceutical discovery and facilitate access to drug candidates with more-complex three dimensional architectures. The project will employ two complementary experimental strategies. One will make use of chemical oxidants that initiate selective hydrogen-atom abstraction from benzylic sites, while the second will exploit electrochemical methods that utilize catalytic electron-, electron/proton-, or hydrogen-atom-abstraction mediators to generate radical intermediates. Both the chemical and electrochemical methods will target benzylic C–H coupling reactions that generate diversely functionalized products. The electrochemical methodology will also target the generation of radicals that undergo addition reactions with (hetero)aromatic rings to produce medicinally relevant aromatic molecules. Several of the benzylic C–H oxidative coupling reactions show effective reactivity with the benzylic coupling partner as the limiting reaction, thereby making them highly appealing for late-stage functionalization of complex molecules. Opportunities toward this end will be explored in collaboration with Merck. Overall, the complementary chemical and electrochemical C–H oxidation methods are poised to greatly impact drug discovery efforts.
项目总结

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Copper-Catalyzed Benzylic C-H Cross-Coupling Enabled by Redox Buffers: Expanding Synthetic Access to Three-Dimensional Chemical Space.
  • DOI:
    10.1021/acs.accounts.3c00580
  • 发表时间:
    2023-12
  • 期刊:
  • 影响因子:
    18.3
  • 作者:
    Si-Jie Chen;S. Krska;S. Stahl
  • 通讯作者:
    Si-Jie Chen;S. Krska;S. Stahl
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shannon S Stahl其他文献

Modular Electrochemical Synthesis Using a Redox Reservoir Paired with Independent Half-Reactions
  • DOI:
    https://doi.org/10.1016/j.joule.2020.11.011
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    39.8
  • 作者:
    Fengmei Wang;Wenjie Li;Rui Wang;Tianqi Guo;Hongyuan Sheng;Hui-Chun Fu;Shannon S Stahl;Song Jin
  • 通讯作者:
    Song Jin

Shannon S Stahl的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shannon S Stahl', 18)}}的其他基金

Catalytic Oxidations for Pharmaceutical Synthesis
药物合成的催化氧化
  • 批准号:
    10541047
  • 财政年份:
    2020
  • 资助金额:
    $ 29.76万
  • 项目类别:
Catalytic Oxidations for Pharmaceutical Synthesis
药物合成的催化氧化
  • 批准号:
    10319588
  • 财政年份:
    2020
  • 资助金额:
    $ 29.76万
  • 项目类别:
Catalytic Oxidations for Pharmaceutical Synthesis
药物合成的催化氧化
  • 批准号:
    10797835
  • 财政年份:
    2020
  • 资助金额:
    $ 29.76万
  • 项目类别:
Catalytic Oxidations for Pharmaceutical Synthesis
药物合成的催化氧化
  • 批准号:
    10078960
  • 财政年份:
    2020
  • 资助金额:
    $ 29.76万
  • 项目类别:
Catalytic Oxidations for Pharmaceutical Synthesis
药物合成的催化氧化
  • 批准号:
    10086140
  • 财政年份:
    2020
  • 资助金额:
    $ 29.76万
  • 项目类别:
Catalytic Oxidations for Pharmaceutical Synthesis
药物合成的催化氧化
  • 批准号:
    10543776
  • 财政年份:
    2020
  • 资助金额:
    $ 29.76万
  • 项目类别:
Palladium-Catalyzed Aerobic Dehydrogenation of Carbon-Carbon Bonds
钯催化碳-碳键有氧脱氢
  • 批准号:
    8794442
  • 财政年份:
    2012
  • 资助金额:
    $ 29.76万
  • 项目类别:
Palladium-Catalyzed Aerobic Dehydrogenation of Carbon-Carbon Bonds
钯催化碳-碳键有氧脱氢
  • 批准号:
    8607575
  • 财政年份:
    2012
  • 资助金额:
    $ 29.76万
  • 项目类别:
Palladium-Catalyzed Aerobic Dehydrogenation of Carbon-Carbon Bonds
钯催化碳-碳键有氧脱氢
  • 批准号:
    8221784
  • 财政年份:
    2012
  • 资助金额:
    $ 29.76万
  • 项目类别:
Palladium-Catalyzed Aerobic Dehydrogenation of Carbon-Carbon Bonds
钯催化碳-碳键有氧脱氢
  • 批准号:
    8449250
  • 财政年份:
    2012
  • 资助金额:
    $ 29.76万
  • 项目类别:

相似海外基金

Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
  • 批准号:
    10374792
  • 财政年份:
    2021
  • 资助金额:
    $ 29.76万
  • 项目类别:
Elucidation and prevention of the mechanism of hepatic sinusoidal obstruction syndrome (SOS) induced by DNA alkylating agents
DNA烷化剂诱发肝窦阻塞综合征(SOS)机制的阐明和预防
  • 批准号:
    21K15255
  • 财政年份:
    2021
  • 资助金额:
    $ 29.76万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
  • 批准号:
    10570900
  • 财政年份:
    2021
  • 资助金额:
    $ 29.76万
  • 项目类别:
Development of individualized therapy by elucidation of molecular mechanisms for hypermutation phenotype induced by treatment with alkylating agents in glioma
通过阐明神经胶质瘤中烷化剂治疗诱导的超突变表型的分子机制来开发个体化治疗
  • 批准号:
    18K09004
  • 财政年份:
    2018
  • 资助金额:
    $ 29.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Reversing intrinsic cancer cell resistance to alkylating agents by histone deacetylase inhibition
通过组蛋白脱乙酰酶抑制逆转癌细胞对烷化剂的内在耐药性
  • 批准号:
    214657440
  • 财政年份:
    2012
  • 资助金额:
    $ 29.76万
  • 项目类别:
    Research Grants
Rerouting alkylating agents to the mitochondria for cancer therapy
将烷化剂重新路由至线粒体用于癌症治疗
  • 批准号:
    247842
  • 财政年份:
    2011
  • 资助金额:
    $ 29.76万
  • 项目类别:
    Studentship Programs
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8105413
  • 财政年份:
    2010
  • 资助金额:
    $ 29.76万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8271313
  • 财政年份:
    2010
  • 资助金额:
    $ 29.76万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8730259
  • 财政年份:
    2010
  • 资助金额:
    $ 29.76万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8676463
  • 财政年份:
    2010
  • 资助金额:
    $ 29.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了